BR0215680A - Composição farmacêutica oral estável - Google Patents

Composição farmacêutica oral estável

Info

Publication number
BR0215680A
BR0215680A BR0215680-6A BR0215680A BR0215680A BR 0215680 A BR0215680 A BR 0215680A BR 0215680 A BR0215680 A BR 0215680A BR 0215680 A BR0215680 A BR 0215680A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
oral pharmaceutical
stable oral
stable
lactose
Prior art date
Application number
BR0215680-6A
Other languages
English (en)
Inventor
Rudolf Perl
Original Assignee
Rudolf Perl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudolf Perl filed Critical Rudolf Perl
Publication of BR0215680A publication Critical patent/BR0215680A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA ORAL ESTáVEL". A presente invenção refere-se a formulações farmacêuticas adequadas de derivados de fosfolipídeo. As composições são não-hidroscópicas, estáveis e facilmente manufaturadas, porque elas são livres de lactose ou pelo menos não contendo mais lactose do que 1 % em peso.
BR0215680-6A 2002-04-26 2002-04-26 Composição farmacêutica oral estável BR0215680A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/002786 WO2003090757A1 (en) 2002-04-26 2002-04-26 Pharmaceutical compositions of phospholipid derivatives

Publications (1)

Publication Number Publication Date
BR0215680A true BR0215680A (pt) 2005-02-01

Family

ID=29266747

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215680-6A BR0215680A (pt) 2002-04-26 2002-04-26 Composição farmacêutica oral estável

Country Status (3)

Country Link
AU (1) AU2002346284A1 (pt)
BR (1) BR0215680A (pt)
WO (1) WO2003090757A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3346525A1 (de) * 1983-12-22 1985-07-04 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
AU756805B2 (en) * 1998-01-22 2003-01-23 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis

Also Published As

Publication number Publication date
AU2002346284A1 (en) 2003-11-10
WO2003090757A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
BR112022024943A2 (pt) Composição oral efervescente compreendendo um ingrediente ativo
BRPI0519414A2 (pt) composiÇço oral, composiÇço em pasta ou gel, e, mÉtodos para inibir crescimento bacteriano na cavidade oral, e para manter saéde sistÊmica
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
BRPI0508833A (pt) formulações galênicas de compostos orgánicos
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
HK1076605A1 (en) Formulations
SE0001899D0 (sv) New compounds
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
BRPI0608291A2 (pt) agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
BR0212069A (pt) Agentes antidiabéticos orais
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
AR032499A1 (es) Composiciones
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
NO20055754L (no) Kolkisosidanaloger
BRPI9916820B8 (pt) composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método
BR0215680A (pt) Composição farmacêutica oral estável
BR0317693A (pt) Derivados de epotilona
BR0308201A (pt) Derivados de quinolina
BRPI0411638A (pt) produto alimentìcio e métodos de preparação de uma formulação

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 12A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.